Search

Your search keyword '"Hunfeld N"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Hunfeld N" Remove constraint Author: "Hunfeld N"
88 results on '"Hunfeld N"'

Search Results

1. Specifieke geneesmiddelen

2. Infusen

4. Farmacokinetiek

5. Hypertensie

9. Circular material flow in the intensive care unit-environmental effects and identification of hotspots

12. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units

13. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

14. Using Residual Blood from the Arterial Blood Gas Test to Perform Therapeutic Drug Monitoring of Vancomycin:An Example of Good Clinical Practice Moving towards a Sustainable Intensive Care Unit

15. Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist:a cohort study

16. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

25. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact

26. Intracerebral hemorrhage in ICU: is it worth treating?

27. ESICM LIVES 2016: part two

34. Quetiapine in Overdosage

35. A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2 C19 polymorphism.

36. Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors.

37. Environmental sustainability in intensive care: the path forward. An ESICM Green Paper.

39. The carbon footprint of a Dutch academic hospital-using a hybrid assessment method to identify driving activities and departments.

40. Nudging intensive care unit personnel towards sustainable behaviour.

43. Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation play a role?

44. Which patients benefit from model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin at the ICU?

46. A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.

47. Circular material flow in the intensive care unit-environmental effects and identification of hotspots.

49. Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.

50. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review.

Catalog

Books, media, physical & digital resources